Next Article in Journal
Growth Hormone Upregulates Melanoma Drug Resistance and Migration via Melanoma-Derived Exosomes
Previous Article in Journal
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
Previous Article in Special Issue
Alectinib vs. Lorlatinib in the Front-Line Setting for ALK-Rearranged Non-Small-Cell Lung Cancer (NSCLC): A Deep Dive into the Main Differences across ALEX and CROWN Phase 3 Trials
 
 
Article

Article Versions Notes

Cancers 2024, 16(15), 2633; https://doi.org/10.3390/cancers16152633
Action Date Notes Link
article xml file uploaded 24 July 2024 11:44 CEST Original file -
article xml uploaded. 24 July 2024 11:44 CEST Update https://www.mdpi.com/2072-6694/16/15/2633/xml
article pdf uploaded. 24 July 2024 11:44 CEST Version of Record https://www.mdpi.com/2072-6694/16/15/2633/pdf
article supplementary file uploaded. 24 July 2024 11:44 CEST - https://www.mdpi.com/2072-6694/16/15/2633#supplementary
article html file updated 24 July 2024 11:46 CEST Original file https://www.mdpi.com/2072-6694/16/15/2633/html
Back to TopTop